Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The type 2 diabetes market has become increasingly crowded, with therapies competing over preferential formulary placement as well as patient share. Using primary research from U.S. endocrinologists, primary care physicians, and managed care organization medical/pharmacy directors, this content examines market access factors in the United States. The interaction between payers and physicians, including how reimbursement decisions impact prescribing and uptake of therapies at the brand level, will help unravel treatment drivers in the second line following metformin monotherapy.
Already a Client? Log in to access this report.